SEC EDGARSEP 31 min read$LRCX

Varadarajan Seshasayee sold $17.4M of LRCX

Varadarajan Seshasayee (Senior Vice President) sold 59,750 shares of LAM RESEARCH CORP (LRCX) at $291.32 ($17.41M total) across 3 trades on 2026-09-02 under a Rule 10b5-1 trading plan.

Original reporting

SEC EDGAR · Varadarajan Seshasayee

Published Sep 3, 2026, 4:00 PM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Sep 4, 2026, 7:15 AM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

AlphAI market briefInsider activity

Primary signal

$LRCX

Bearish

high confidence

Mentioned

$LRCX

Relevance

6/10

AlphAI data visualization · based on SEC EDGAR

Decision brief

The 30-second read

$LRCXBearishMed

Why it matters

The disclosed sale reduces insider ownership, which can be interpreted as a negative signal, but the 10b5‑1 plan suggests it was pre‑planned.

Market read

The filing provides fresh, material data on insider holdings that could influence short‑term trading decisions for LRCX.

What to watch

Potential tax planning or diversification motives are not disclosed.

Relevance 6/10Novelty 7/10Timing: filing date 2026-09-03 (after market)

Background

SEC Form 4 filing discloses insider transactions; such filings are primary sources of material information.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$LRCXBearishHigh confidence

Context

Senior Vice President Varadarajan Seshasayee sold 59,750 shares for $17.4M via a 10b5‑1 plan, reducing his stake to 205,546 shares.

Expected impact

Possible modest downside pressure over the next few days.

Evidence & confidence

The sale size ($17.4M) is material for a senior executive at a mid‑cap semiconductor firm, and the transaction was disclosed on the filing date, making it fresh actionable information.

Market effects

Sector

May prompt scrutiny of other semiconductor insiders' holdings.

Regional

Limited to U.S. markets where Lam Research trades.

Global

Low; primarily affects Lam Research investors.

Counterpoint

What could challenge this read

The sale could be a routine liquidity event under a pre‑arranged plan, not a bearish signal.

Key entities

Company
Lam Research Corp.
Semiconductor equipment manufacturer (ticker LRCX).
Individual
Varadarajan Seshasayee
Senior Vice President at Lam Research.

Read at source ← All news

OCT 13

$BACMed

US Futures Hold Steady Ahead of Inflation Report

US stock futures were stable on Wednesday ahead of the September inflation report. Bank of America shares fell over 2% after $1.2B in penalties from regulators. Memory stocks declined due to AI investment concerns and Chinese competition, with Micron down 4.6%. Financial stocks also dropped post-earnings, including Citigroup (-5.3%) and Wells Fargo (-2.6%).

tradingview.com2 min

OCT 13

$AMATMed

Applied Materials shares slide as chip equipment outlook remains uncertain

Applied Materials (AMAT) shares dropped 7.5% after it declined to provide a wafer fabrication equipment (WFE) spending forecast, citing uncertainties. CEO Gary Dickerson expressed long-term confidence in AI-driven demand but highlighted near-term variables. Semiconductor equipment peers KLA Corp., Lam Research, and ASML Holding also fell. ASML's upcoming earnings are in focus.

investing.com4 min

OCT 9

$LRCXHigh

Wells Fargo Adjusts Price Target on Lam Research to $355 From $350

Wells Fargo raised its price target for Lam Research (LRCX) to $355 from $350. Morgan Stanley also adjusted its target to $385 from $367, maintaining an overweight rating. LRCX shares closed at $320.59, down 2.71%.

marketscreener.com1 min

OCT 9

$LRCXLow

Round Design Infringement Case Against Lam Research < Supply Chain < 기사본문

BCNC, a South Korean semiconductor component maker, was ordered by a Seoul court to stop producing and distributing certain edge-ring products, pay damages, and destroy existing inventory, following a design-right infringement lawsuit by Lam Research. The court partially dismissed Lam Research's claims. Both companies are also involved in separate patent disputes, with mixed rulings. BCNC plans to appeal the decision.

thelec.net2 min

OCT 8

$LRCXMedAI 8/10

Lam Research Stocks Fall 2.1% as AI Spending Lifts Target 33%

Lam Research (LRCX) shares fell 2.42% to $325.81 on October 7, despite Cantor Fitzgerald raising its price target to $425 from $320. The company reported June-quarter revenue of $6.72 billion, up 15.1% from the prior quarter, with improved margins. Cantor's target suggests 30.4% upside, but shares are 106.68% above GF Value™ estimate of $157.64.

gurufocus.com2 min

OCT 6